E-LIB Suche - Ergebnisse für: Hüppe, D.

1

N02 Inflammatory bowel disease patients with impaired quali..:

Hartmann, P ; Zemke, J ; Plachta-Danielzik, S...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i2199-i2200 , 2024

Link: https://doi.org/10.1093/..

2

Feasibility and long-term efficacy of a proactive health pr..:

Hüppe, A. ; Zeuner, C. ; Karstens, S....
BMC Health Services Research. 19 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..

3

Has increased rollout of DAA therapy decreased the burden o..:

Rockstroh, J. ; Boesecke, C. ; Ingiliz, P....
Journal of Hepatology. 68 (2018) - p. S325-S326 , 2018

Link: https://doi.org/10.1016/..

4

Disease progression is affected by pattern of serum alanine..:

Knop, V. ; Vermehren, J. ; Petersen, Jörg...
Journal of Hepatology. 68 (2018) - p. S496 , 2018

Link: https://doi.org/10.1016/..

5

Calanus finmarchicus seasonal cycle and diapause in relatio..:

Häfker, N. Sören ; Teschke, M. ; Last, K. S....
Limnology and Oceanography. 63 (2018) 6 - p. 2815-2838 , 2018

Link: https://doi.org/10.1002/..

6

Calanus finmarchicus seasonal cycle and diapause in relatio..:

Häfker, N. Sören ; Teschke, M. ; Last, K. S....
Limnology and Oceanography. 63 (2018) 6 - p. 2815-2838 , 2018

Link: https://www.jstor.org/st..

7

Significant changes of HCV patient characteristics over tim..:

Christensen, S. ; Ingiliz, P. ; Schulze Zur Wiesch, J....
Journal of Hepatology. 68 (2018) - p. S289-S290 , 2018

Link: https://doi.org/10.1016/..

8

Durability of HBsAg loss during or after antiviral treatmen..:

Teuber, G. ; Sprinzl, M. ; Hüppe, D....
Journal of Hepatology. 68 (2018) - p. S506 , 2018

Link: https://doi.org/10.1016/..

9

Real‐world experience with the all‐oral, interferon‐free re..:

Welzel, T. M. ; Hinrichsen, H. ; Sarrazin, C....
Journal of Viral Hepatitis. 24 (2017) 10 - p. 840-849 , 2017

Link: https://doi.org/10.1111/..

10

Real‐world use, effectiveness and safety of anti‐viral trea..:

Cornberg, M. ; Petersen, J. ; Schober, A....
Alimentary Pharmacology & Therapeutics. 45 (2017) 5 - p. 688-700 , 2017

Link: https://doi.org/10.1111/..

11

Effectiveness and Safety of DAA Combination Therapies for T..:

Welzel, T. ; Schott, E. ; Petersen, J....
Journal of Hepatology. 64 (2016) 2 - p. S824-S825 , 2016

Link: https://doi.org/10.1016/..

12

Persistence to Entecavir Treatment for Chronic Hepatitis B ..:

Petersen, J. ; Wilke, T. ; Mauss, S....
Journal of Hepatology. 64 (2016) 2 - p. S593-S594 , 2016

Link: https://doi.org/10.1016/..

13

Treatment Outcomes for Hepatitis C Genotype 1 Infection wit..:

Mauss, S. ; Buggisch, P. ; Böker, K.H.W....
Journal of Hepatology. 64 (2016) 2 - p. S820 , 2016

Link: https://doi.org/10.1016/..

14

Safety and Efficacy of IFN- Free Antiviral Therapies in Adv..:

Deterding, K. ; Buggisch, P. ; Klinker, H....
Journal of Hepatology. 64 (2016) 2 - p. S787 , 2016

Link: https://doi.org/10.1016/..

15

Treatment of Patients with Hepatitis C Virus (HCV) Genotype..:

Cornberg, M. ; Buggisch, P. ; Schober, A....
Journal of Hepatology. 64 (2016) 2 - p. S794 , 2016

Link: https://doi.org/10.1016/..